Abstract
We tested the fluoroquinolone susceptibility of 499 Salmonella enterica isolates collected from travelers returning to Finland during 2003-2007. Among isolates from travelers to Thailand and Malaysia, reduced fluoroquinolone susceptibility decreased from 65% to 22% (p = 0.002). All isolates showing nonclassical quinolone resistance were from travelers to these 2 countries.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Anti-Infective Agents / pharmacology
-
Ciprofloxacin / pharmacology
-
Drug Resistance, Bacterial*
-
Finland
-
Fluoroquinolones / pharmacology*
-
Humans
-
Microbial Sensitivity Tests
-
Nalidixic Acid / pharmacology
-
Salmonella Infections / microbiology
-
Salmonella enterica / classification
-
Salmonella enterica / drug effects*
-
Salmonella enterica / isolation & purification
-
Serotyping
-
Travel*
Substances
-
Anti-Bacterial Agents
-
Anti-Infective Agents
-
Fluoroquinolones
-
Nalidixic Acid
-
Ciprofloxacin